A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and […]
Vaccination programs are known to be effective to both promote the prudent use of antibiotics and to prevent the spread of AMR. JPIAMR, in partnership with the Medical Research Council and BactiVac Network, […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when […]
On 26 July, James J. Collins and Richard Lee will be discussing the use of Synthetic biology and interdisciplinary approaches for antibiotic discovery.
In this webinar, the speakers will discuss will provide an overview of basic animal models and explain the basis for their selection and limitations for specific situations and needs to […]
On 23 August, Michael N. Dudley and Glenn Dale will discuss the Challenges and options in developing antibiotic combinations.
Since 2015, the World Antimicrobial Resistance Congress has attracted top thought leaders, hospitals, companies, and policymakers as the annual, go-to event in the Antimicrobial Resistance (AMR) space. We have grown […]
The EMBO Workshop on Tuberculosis 2022, originally planned for September 2020 and postponed to 2022 due to the Covid-19 pandemic, has recently received again the support from EMBO, and is now […]
Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society […]
